ADAMANTINOMATOUS CRANIOPHARYNGIOMA
Clinical trials for ADAMANTINOMATOUS CRANIOPHARYNGIOMA explained in plain language.
Never miss a new study
Get alerted when new ADAMANTINOMATOUS CRANIOPHARYNGIOMA trials appear
Sign up with your email to follow new studies for ADAMANTINOMATOUS CRANIOPHARYNGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug targets genetic weakness in advanced tumors
Disease control Recruiting nowThis early-stage trial is testing a new drug called FOG-001 for people with advanced or spreading cancers that have specific genetic mutations. Researchers want to find the safest dose and see if the drug can shrink tumors or slow cancer growth. The study will include 575 partici…
Matched conditions: ADAMANTINOMATOUS CRANIOPHARYNGIOMA
Phase: PHASE1, PHASE2 • Sponsor: Parabilis Medicines, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Arthritis drug could be new weapon against rare childhood brain tumor
Disease control Recruiting nowThis study is testing whether an existing arthritis drug called Actemra (tocilizumab) can help control a rare and difficult-to-treat brain tumor in children and young adults. The trial will enroll up to 38 patients aged 1 to 39 years who have a recurrent or progressive tumor call…
Matched conditions: ADAMANTINOMATOUS CRANIOPHARYNGIOMA
Phase: PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Mar 03, 2026 14:06 UTC